|
|
500 Kendall Square
Cambridge, MA 02142 USA
phone:(617) 252-7500
fax:617 252 7600
|
|
| Symbol |
GENZ |
| Exchange |
NASDAQ |
| Founded |
1981 |
| Employees |
9 |
|
|
| www.genzyme.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| A product portfolio focused on rare genetic disorders, renal disease and osteoarthritis. |
|
| Management |
| Henri A. Termeer, Chairman, President and Chief Executive Officer; Jason A. Amello, Corporate Controller; Chief Accounting Officer; John Butler, Senior Vice President; President, Cardiometabolic & Renal; Zoltan Csimma, Senior Vice President, Chief Human Resources Officer; Thomas J. DesRosier, Esquire, Senior Vice President; General Counsel; Chief Legal Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| inherited disorders, kidney disease, orthopaedics, cancer, transplant |
|
|
|
| Description |
|
Genzyme Corporation broad product portfolio is focused on rare genetic disorders, renal disease and osteoarthritis and includes an array of diagnostic products and services. Genzyme researches into novel approaches to cancer, heart disease and other areas of unmet medical need. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
